Clinical and Experimental Allergy最新文献

筛选
英文 中文
High Stratum Corneum Hydration May Predict Atopic Dermatitis Development in Moisturised Infants. 高角质层水化可以预测婴儿特应性皮炎的发展。
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-10-09 DOI: 10.1111/cea.70154
Tomoki Yaguchi, Kenji Toyokuni, Yusuke Inuzuka, Hiroya Ogita, Risa Fukuda, Kazue Yoshida, Tatsuki Fukuie, Yukihiro Ohya, Kiwako Yamamoto-Hanada
{"title":"High Stratum Corneum Hydration May Predict Atopic Dermatitis Development in Moisturised Infants.","authors":"Tomoki Yaguchi, Kenji Toyokuni, Yusuke Inuzuka, Hiroya Ogita, Risa Fukuda, Kazue Yoshida, Tatsuki Fukuie, Yukihiro Ohya, Kiwako Yamamoto-Hanada","doi":"10.1111/cea.70154","DOIUrl":"https://doi.org/10.1111/cea.70154","url":null,"abstract":"","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Allergen-Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy. 用于被动过敏免疫治疗的过敏原特异性人单克隆IgG抗体
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-10-08 DOI: 10.1111/cea.70153
Scott A Smith, Cosby A Stone, Alain Jacquet
{"title":"Allergen-Specific Human Monoclonal IgG Antibodies for Use in Passive Allergy Immunotherapy.","authors":"Scott A Smith, Cosby A Stone, Alain Jacquet","doi":"10.1111/cea.70153","DOIUrl":"https://doi.org/10.1111/cea.70153","url":null,"abstract":"<p><p>The last decades have shown the number of subjects developing allergic rhinitis (AR), allergic asthma (AA), atopic dermatitis (AD), and food allergy rose continuously worldwide. To cure these allergic diseases, allergen-specific immunotherapy (AIT) represents the unique treatment capable of providing clinical outcomes through the induction of long-term immunological tolerance. Despite proven efficacy, the duration of treatment, AIT-associated side effects, and the difficulty in identifying potential responders by diagnosis lead to poor patient compliance. Clinical investigations evidenced the role of blocking IgG antibodies induced by AIT in long-term tolerance. These observations suggested that passive allergy immunotherapy (PAIT) with low doses of allergen-specific blocking IgG antibodies represents an elegant alternative to frequent administrations of allergen extracts. Tremendous technological progress in the discovery/production of fully human monoclonal antibodies (mAbs) with very low immunogenicity has been made in the last decades, and these therapeutic antibodies revolutionised the treatment of cancers or infectious diseases. The recent advances in the isolation of rare allergen-specific IgE+ B cells and the generation of human antibodies in transgenic mice made possible the production of human monoclonal blocking antibodies against any allergen, sharing the same affinity with the corresponding naturally occurring IgE. This comprehensive review will describe the first promising preclinical and clinical data obtained with antibody cocktails targeting several IgE epitopes to some key single allergens. PAIT is safe and effective for the downregulation of the allergic response. Compared with conventional extract-based AIT, the positive outcomes could require much less dosing.</p>","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Approach to Chronic Rhinosinusitis Based on Endotype: Difference Between East and West. 基于内型的慢性鼻窦炎治疗方法:东西方差异。
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-10-02 DOI: 10.1111/cea.70150
Junhai Chen, Linlu Wang, Xinyue Wang, Yana Zhang, Qintai Yang
{"title":"Treatment Approach to Chronic Rhinosinusitis Based on Endotype: Difference Between East and West.","authors":"Junhai Chen, Linlu Wang, Xinyue Wang, Yana Zhang, Qintai Yang","doi":"10.1111/cea.70150","DOIUrl":"https://doi.org/10.1111/cea.70150","url":null,"abstract":"<p><p>Heterogeneity among CRSwNP patients in Western and Eastern countries leads to differences in management. Type 2 (T2) inflammation accounts for the majority of CRSwNP patients in Western countries, while non-T2 inflammation is the main endotype in CRSwNP patients in Eastern countries. Precise identification of T2 inflammation holds significant promise for optimising treatment outcomes. The treatment of T2 inflammation-biased CRSwNP primarily involves glucocorticoids, reboot surgery, and T2 biologics, while non-T2 inflammation-dominant CRSwNP is mainly treated with macrolide antibiotics.</p>","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145205763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Safe and Effective 7 Week Updosing Protocol for Bee and Wasp Venom Immunotherapy. 一种安全有效的蜜蜂和黄蜂毒液免疫治疗7周升级方案。
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-09-30 DOI: 10.1111/cea.70149
Usmaan Ahmed, Yitong Shen, Robert L Yellon, Jacqui Galloway, Priya Sellaturay, Shuaib Nasser, Padmalal Gurugama
{"title":"A Safe and Effective 7 Week Updosing Protocol for Bee and Wasp Venom Immunotherapy.","authors":"Usmaan Ahmed, Yitong Shen, Robert L Yellon, Jacqui Galloway, Priya Sellaturay, Shuaib Nasser, Padmalal Gurugama","doi":"10.1111/cea.70149","DOIUrl":"https://doi.org/10.1111/cea.70149","url":null,"abstract":"","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145191055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Approaches to Allergic Disease Characterisation: Comprehensive Antibody Profiling and Non-Invasive Metabolomics. 变态反应性疾病表征的创新方法:综合抗体谱分析和非侵入性代谢组学。
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-09-30 DOI: 10.1111/cea.70152
Mohamed H Shamji, Robert J Boyle
{"title":"Innovative Approaches to Allergic Disease Characterisation: Comprehensive Antibody Profiling and Non-Invasive Metabolomics.","authors":"Mohamed H Shamji, Robert J Boyle","doi":"10.1111/cea.70152","DOIUrl":"https://doi.org/10.1111/cea.70152","url":null,"abstract":"","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145191098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Incidence of Addiction and Its Risk Factors in Chinese Chronic Urticaria Patients. 中国慢性荨麻疹患者成瘾发生率及其危险因素分析。
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-09-29 DOI: 10.1111/cea.70151
Xinyu Shui, Yu Jiang, Cong Peng, Qiaozhi Cao, Jie Li
{"title":"The Incidence of Addiction and Its Risk Factors in Chinese Chronic Urticaria Patients.","authors":"Xinyu Shui, Yu Jiang, Cong Peng, Qiaozhi Cao, Jie Li","doi":"10.1111/cea.70151","DOIUrl":"https://doi.org/10.1111/cea.70151","url":null,"abstract":"","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145191145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal ImmunoCAP Aspergillus fumigatus-Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study. 最佳免疫cap烟曲霉特异性IgE阈值检测成人哮喘变应性支气管肺曲霉病:诊断准确性研究
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-09-26 DOI: 10.1111/cea.70148
Ritesh Agarwal, Puneet Saxena, Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Sahajal Dhooria, Mani Singh, Mandeep Garg, Ashutosh N Aggarwal, Shivaprakash M Rudramurthy, Arunaloke Chakrabarti
{"title":"Optimal ImmunoCAP Aspergillus fumigatus-Specific IgE Threshold for Detecting Allergic Bronchopulmonary Aspergillosis in Adults With Asthma: A Diagnostic Accuracy Study.","authors":"Ritesh Agarwal, Puneet Saxena, Valliappan Muthu, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Sahajal Dhooria, Mani Singh, Mandeep Garg, Ashutosh N Aggarwal, Shivaprakash M Rudramurthy, Arunaloke Chakrabarti","doi":"10.1111/cea.70148","DOIUrl":"https://doi.org/10.1111/cea.70148","url":null,"abstract":"<p><strong>Background: </strong>Allergic bronchopulmonary aspergillosis (ABPA) requires screening in adults with asthma using Aspergillus fumigatus-specific IgE (Af-IgE). The current Af-IgE threshold of 0.35 kUA/L has low specificity, leading to unnecessary downstream testing.</p><p><strong>Objectives: </strong>To determine an optimal Af-IgE threshold that maintains high sensitivity while improving specificity for ABPA screening in adults with asthma.</p><p><strong>Methods: </strong>We performed a diagnostic accuracy study of prospectively collected data using distinct derivation and validation cohorts in a tertiary care setting. The index test was ImmunoCAP Af-IgE at thresholds of 0.35, 0.70 and 0.90 kUA/L. The reference standard was the 2024 ISHAM-ABPA criteria applied by investigators aware of all test results.</p><p><strong>Results: </strong>We included 543 consecutive asthmatic subjects investigated for possible ABPA in the derivation cohort (July 2017-September 2018) and 375 subjects with established asthma and ABPA in the validation dataset (January 2020-December 2023). ABPA prevalence was 19.5% (106/543) in derivation and 69.6% (261/375) in validation cohorts. Bayesian latent class analysis estimated a 0.3 kUA/L cut-off but did not improve specificity; frequentist analysis showed model misfit. In the validation cohort, increasing the threshold from 0.35 to 0.70 kUA/L improved specificity from 66.7% (95% CI, 57.6-74.7) to 72.8% (95% CI, 64.0-80.1; p = 0.016) without significant sensitivity reduction (100% to 98.9%; 95% CI, 96.7-99.6; p = 0.25). No patients with bronchiectasis were missed. At 0.90 kUA/L, sensitivity significantly decreased (97.7%; 95% CI, 95.1-98.9; p = 0.031).</p><p><strong>Conclusions: </strong>ImmunoCAP Af-IgE threshold of 0.70 kUA/L optimised diagnostic performance for ABPA screening in adults with asthma, potentially reducing unnecessary confirmatory testing.</p>","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145148145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Atopic Sensitisation From 1 to 5 Years of Age: Longitudinal Data From the MIS BAIR Trial. 1至5岁特应性致敏的变化:来自MIS BAIR试验的纵向数据。
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-09-22 DOI: 10.1111/cea.70144
Nicole L Messina, Laure F Pittet, Emily K Forbes, Kaya Gardiner, Katie L Flanagan, Anne-Louise Ponsonby, Roy Robins-Browne, Frank Shann, Mike South, Peter Vuillermin, Susan Donath, Dan Casalaz, Nigel Curtis
{"title":"Changes in Atopic Sensitisation From 1 to 5 Years of Age: Longitudinal Data From the MIS BAIR Trial.","authors":"Nicole L Messina, Laure F Pittet, Emily K Forbes, Kaya Gardiner, Katie L Flanagan, Anne-Louise Ponsonby, Roy Robins-Browne, Frank Shann, Mike South, Peter Vuillermin, Susan Donath, Dan Casalaz, Nigel Curtis","doi":"10.1111/cea.70144","DOIUrl":"https://doi.org/10.1111/cea.70144","url":null,"abstract":"","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remission and Recurrence of Food Protein-Induced Enterocolitis Syndrome: Insights From Oral Food Challenge Outcomes. 食物蛋白诱导的小肠结肠炎综合征的缓解和复发:来自口服食物挑战结果的见解。
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-09-19 DOI: 10.1111/cea.70146
Kotaro Umezawa, Kiwako Yamamoto-Hanada, Miori Sato, Mami Shimada, Daichi Suzuki, Fumi Ishikawa, Seiko Hirai, Mayako Saito-Abe, Kenji Toyokuni, Ichiro Nomura, Tatsuki Fukuie, Yukihiro Ohya
{"title":"Remission and Recurrence of Food Protein-Induced Enterocolitis Syndrome: Insights From Oral Food Challenge Outcomes.","authors":"Kotaro Umezawa, Kiwako Yamamoto-Hanada, Miori Sato, Mami Shimada, Daichi Suzuki, Fumi Ishikawa, Seiko Hirai, Mayako Saito-Abe, Kenji Toyokuni, Ichiro Nomura, Tatsuki Fukuie, Yukihiro Ohya","doi":"10.1111/cea.70146","DOIUrl":"https://doi.org/10.1111/cea.70146","url":null,"abstract":"","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic N-Acylethanolamines and Other Lipid Mediators Are Associated With NSAID-Exacerbated Respiratory Disease. 系统性n -酰基乙醇胺和其他脂质介质与非甾体抗炎药加重的呼吸系统疾病有关
IF 5.2 2区 医学
Clinical and Experimental Allergy Pub Date : 2025-09-18 DOI: 10.1111/cea.70145
Viljami E Salmi, Annina Lyly, Mikko Neuvonen, Elmo Saarentaus, Mikko Niemi, Sanna Toppila-Salmi
{"title":"Systemic N-Acylethanolamines and Other Lipid Mediators Are Associated With NSAID-Exacerbated Respiratory Disease.","authors":"Viljami E Salmi, Annina Lyly, Mikko Neuvonen, Elmo Saarentaus, Mikko Niemi, Sanna Toppila-Salmi","doi":"10.1111/cea.70145","DOIUrl":"https://doi.org/10.1111/cea.70145","url":null,"abstract":"","PeriodicalId":10207,"journal":{"name":"Clinical and Experimental Allergy","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145084904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信